Motor racing is both a physically challenging and mentally demanding sport.  Its associated with a high degree of safety risk for drivers, whereby the slightest error could lead to fatal consequences.   Drowsiness and inattentiveness are amongst the most dangerous risks faced by any driver, yet alone a race car driver who’s preparing to be at...

September is World Alzheimer’s month, the international campaign which raises awareness and challenges the stigma that surrounds dementia. Around the world 50 million people have dementia, and each year there are nearly 10 million new cases. The total number of people with dementia is projected to reach 82 million by 2030! With over 100 forms...

Latest News Today, Melbourne based Medtech company, Optalert Australia, were announced as the recipient of the Australian Government – Automotive Innovation Lab Access Grant (AILAG).   The grant will be used to advance the development of the Optalert Video Automotive technology solution for the objective, early prediction of drowsiness and attentiveness monitoring. The project aims to...

Connecting the physical world with the digital world Industry 4.0 fundamentally changes the way in which businesses create and capture value. This shift is enabled by a set of technologies including autonomous robots, simulation technology, system integration, the Internet of Things (IoT), cybersecurity, cloud computing, additive manufacturing, augmented reality and big data. Industry 4.0 technologies...

The National Transport Commission (NTC) and the Cooperative Research Centre for Alertness, Safety and Productivity (Alertness CRC) today released the results of a world-first study into heavy vehicle driver fatigue. The two-year scientific study evaluated alertness monitoring technology and the impacts of work shifts on driver alertness. It analysed shift start time, the number of...

  BIO International Convention is back in Philadelphia, June 3-6, to celebrate the globally important innovations in biotech that start with one: one meeting, one theory, one trial, one breakthrough. Optalert look forward to joining the global biotech community during partnering sessions and will be available for meetings through the official Bio2019 partnering portal, opening...

Optalert is pleased to introduce the BlinQ system for the measurement of drowsiness or wakefulness in clinical trials. Optalert uses advanced patented algorithms to determine the exact drowsiness or wakefulness of a subject.  By applying Artificial Intelligence techniques and machine learning Optalert has been able to objectively quantify drowsiness or wakefulness.  Utilising the Johns Drowsiness Scale (JDS), Optalert’s future-proofed...